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CASE REPORT
A Fatal Rectus Sheath Hematoma After a Myasthenia Crisis: 
A Case Report
Robert G. Michaud, MD, MPH,1 Lesley B. Gordon, MD, MS1,2
1Tufts University School of Medicine, Boston, MA, 2 Maine Medical Partners Hospital Medicine, Portland, ME
Introduction:  Rectus sheath hematomas (RSH) are generally caused by damage to the inferior epigastric artery. 
They are rare causes of abdominal pain or acute anemia due to blood loss, but they are an important 
diagnostic consideration because they can be cryptic and potentially fatal.
Clinical Findings: An 85-year-old female who was admitted to the hospital for 10 days with a myasthenia crisis was 
abruptly hypotensive with a tender abdominal mass in the left lower quadrant that subtly crossed the 
midline. She was on prophylactic anticoagulation during her hospitalization.
 The patient was initially stabilized with fluids and given one unit of packed red blood cells. Results from a 
computed tomography angiography of her abdomen and pelvis showed a type III RSH. She underwent 
a percutaneous embolization of her inferior epigastric artery via interventional radiology. Unfortunately, 
she did not recover and was transitioned to hospice, where she died 1 day after discharge.
Conclusion:  Classic teaching associates RSHs with systemic anticoagulation and a physical exam notable for a 
mass not crossing the midline. However, a wider range of presentations, including an abdominal mass 
that crosses the midline, can occur. Other important risk factors include frailty, immunosuppression, and 
possibly abdominal injections (particularly heparin).
Keywords:  rectus sheath hematoma, abdominal injection, case report
CASE PRESENTATION
An 85-year-old female, whose medical history 
noted a recent diagnosis of myasthenia gravis, 
was transferred to our tertiary care hospital in 
a myasthenia crisis with increasing generalized 
weakness and respiratory failure. Her home 
medications included prednisone, but no 
antiplatelet or anticoagulant medications. Due to 
her declining respiratory status, she was intubated 
on hospital day 2. She was given 5 doses of 
intravenous immunoglobulin (20 g per dose) and 
methylprednisolone (1 g per dose). She remained 
on prophylactic anticoagulation throughout her 
hospitalization. She received subcutaneous 
abdominal injections of enoxaparin 40 mg daily at 
the outside hospital and then was transitioned to 
heparin 5000 units every 12 hours at our institution. 
She received no other abdominal injections. She 
was extubated on hospital day 6, transitioned to 
prednisone 40 mg daily, and transferred to the 
general medicine unit. She was medically stable 
and being prepared for discharge to a skilled 
nursing facility.
On hospital day 11, she developed severe 
abdominal pain in her left lower quadrant. She 
was hypotensive to 80/50 mmHg (prior range: 140-
170/60-80 mmHg), her extremities were cool, and 
she was somnolent. She had a new 3.5-cm firm, 
tender mass in her left lower quadrant that subtly 
crossed the midline. She was temporarily stabilized 
with 2 L lactated ringers and 1 unit packed red 
blood cells. Her hemoglobin dropped from 11.7 g/dL 
to 9.7 g/dL. Given our concern for intra-abdominal 
pathology, she underwent a computed tomography 
angiography of her abdomen and pelvis. The scan 
revealed a large hematoma that originated in the 
left rectus sheath, with active extravasation from 
the inferior epigastric artery, and expansion into 
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the extraperitoneal space within the pelvis (Figure 
1). Interventional radiology successfully embolized 
the inferior epigastric artery, but the patient had 
persistent hypotension after resuscitation and 
continued to decline. She developed ischemic 
hepatitis and acute renal failure. Given her 
continued decrease in consciousness and prior 
goals of care, she was transitioned to comfort 
measures and discharged to hospice. She died 1 
day after discharge.
DISCUSSION
A rare cause of abdominal pain is a rectus sheath 
hematoma (RSH), which accounts for approximately 
1.8% of cases.1-4 A RSH is a collection of blood 
within the aponeurosis of the rectus abdominis 
muscle that is due to damage to the epigastric 
artery or the rectus muscle.3,4 The rectus abdominis 
muscles are separated by the linea alba, accounting 
for the unilateral nature of most RSHs. They are 
surrounded by the aponeuroses of the internal 
oblique, transversus abdominis, and external 
oblique muscles, which together form the rectus 
sheath.4,5 The inferior epigastric artery is particularly 
vulnerable to injury because it runs along the 
posterior surface of the rectus abdominis muscle 
and then penetrates the rectus sheath at the arcuate 
line. This line is where the rectus sheath transitions 
from surrounding the rectus abdominis muscle to 
only running along the anterior surface (Figure 
2).6 Although RSHs can occur above the arcuate 
line, they are generally less severe and self-limited 
because the surrounding sheath tamponades the 
hematoma and prevents its expansion.7 Thus, most 
RSHs occur in the lower abdominal quadrants and 
are often more severe.6,7
There are 3 types of RSHs (Figure 3). Type I 
hematomas are mild, intramuscular, and unilateral 
hemorrhages that do not lead to hemodynamic 
instability. These hematomas can be managed 
conservatively and generally resolve within 30 
days.3,4 Type II hematomas are larger, and the 
hemorrhage extends between the transversalis 
fascia and rectus abdominis. This hematoma 
can lead to a decreased hematocrit and may 
require bed rest, hemodynamic assistance, and 
analgesia. Type III hematomas, the most severe, 
are hemorrhages that extend to the peritoneum and 
perivascular space.3,4 These hematomas generally 
require further hemodynamic assistance with blood 
transfusions and are more likely to need surgery 
or percutaneous interventions.3,4 Type II and III 
RSHs may cross the midline, involving both rectus 
muscles, and typically resolve within 3 months.3,4,6 
The average RSH volume or estimated blood 
loss varies widely. One study found that the mean 
volume ranged from 612.5 mL (SD = 225 mL) to 
940 mL (SD = 371.5 mL). Another study found that 
it ranged from 687 ± 614 mL among conservatively 
managed patients to 2353 ± 1657 mL among 
patients who underwent embolization.8,9
A review of 126 cases at a single medical center 
identified the top 5 presenting signs and symptoms 
of RSH, which included abdominal pain (84%), 
abdominal wall mass (63%), a decrease in 
hemoglobin by 0.4 g/dL or more (55%), abdominal 
wall ecchymosis (17%), and nausea or vomiting 
(15%).2 Factors associated with RSHs included 
advanced age, systemic anticoagulation, chronic 
kidney disease (stage 3 or greater), steroid or 
immunosuppressant treatment, trauma, and 
abdominal injections. More recent cases also 
found abdominal wall straining (e.g., coughing) as 
a factor.1,2,4 RSHs are two to three times more likely 
to occur in females than in males.1,2,4
Figure 1. Computed tomography angiography of 
abdomen and pelvis. The scan revealed a type 
III rectus sheath hematoma that expanded into 
the extraperitoneal space within the pelvis. Arrow, 
contrast extravasation from the inferior epigastric 
artery.
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Figure 2. Axial illustration of the abdominal muscles surrounding the arcuate line. The abdominal muscles 
(A) above and (B) below the arcuate line at which the rectus sheath transitions from surrounding the 
rectus abdominis muscle to only covering the anterior portion.
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A – Type I RSH
B – Type II RSH
C – Type III RSH
Figure 3. Illustration of the 3 types of rectus sheath hematomas in the axial view. A, Type I hematoma is 
within the rectus abdominis muscle. B, Type II hematoma extends outside the muscle and dissects the 
surrounding fascial layers. C, Type III hematoma extravasates to the peritoneum and perivascular space. 
RSH, rectus sheath hematoma. 
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Our patient was not given therapeutic 
anticoagulation. She was female, elderly, and given 
prophylactic heparin injections in her abdomen 
and pulse therapy doses of corticosteroids 
(defined as ≥ 250mg of prednisone-equivalent 
per day). These factors likely increased her risk 
for developing a RSH.10 Although RSHs tend to 
present as a unilateral mass, they can cross the 
midline, as demonstrated by this case. With the 
increasing prevalence of systemic anticoagulation, 
the occurrence of RSHs may increase.4 RSHs are 
rarely fatal (~2-4% overall), but the fatality risk 
may increase in patients receiving anticoagulation 
treatment.2,4,6,11 Physicians must carefully consider 
a RSH in patients who develop a painful abdominal 
mass, regardless of midline involvement, to ensure 
prompt diagnosis and treatment.
Prior case reports highlighted that RSHs may be 
associated with abdominal injections and steroids or 
immunosuppressants.1,12-14 Systemic corticosteroids 
have been linked with spontaneous bruising and 
disrupted wound healing.15 Future studies should 
investigate how corticosteroid dose may affect the 
development and outcomes of RSHs. Additionally, 
the association between abdominal injections and 
RSHs should be explored. If abdominal injections 
increase the risk of RSHs, this risk could be 
mitigated by choosing other locations (eg, thighs 
or upper arms) for prophylactic anticoagulation or 
insulin injections in the hospital.
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